Magdalena Staniszewska Bio

MAGDALENA STANISZEWSKA, Ph.D.
Chief Science Officer / Project Leader / Scientist

Graduated with M.S. in Engineering, Specialty: Biotechnology from the Wroclaw University of Technology
Obtained PhD in Biological Sciences, Specialty: Immunochemistry from the Institute of Immunology and Experimental Therapy, Polish Academy of Sciences in Wroclaw, Poland and Habilitation Degree in Medical Sciences, Specialty Medical Biology/Biochemistry
Completed postdoctoral training at Case Western Reserve University, Cleveland, OH and Schepens Eye Research Institute/Harvard Medical School, Boston, MA
A scientist with broad experience in discovering molecular bases of diseases, identifying targets and developing novel therapeutic strategies for diabetic complications, cancer and eye diseases.

Professional experience

Expertise and accomplishments in understanding of the diabetic, age-related and inherited ocular complications, revealing novel therapeutic options were gained at the top world academic institutions – Harvard Medical School, Boston, MA and Case Western Reserve University, Cleveland, OH. Co-invented analytical tools and diagnostic markers of pathological neovessels – components of the proliferative retinal diseases and cancer tumor. Described the role of novel genes causing blindness and generated animal models for developing gene therapy and regenerative medicine. Endeavore to provide excellent research, teaching and peer-revision of the scientific work. Successful in developing interdisciplinary collaborations between academia and business in order to build products upon revolutionary ideas.
Patent aplication, currently marketed by Novartis AG
http://patents.justia.com/patent/8722015
Track record of scientific publications and public speaking.
http://www.lekarski.umed.wroc.pl/sites/default/files/struktura/lekarski/dziekanat/habilitacje/Magdalena_Maria_Staniszewska_autoreferat.pdf

Core speciality

Cell biology, ocular diseases, diabetic and age-related complications, disease targets identification, targeted and gene therapies

Worked for

-Institute Immunology and Experimental Therapy, Polish Academy of Sciences in Wroclaw, Poland
-Harvard Medical School, Schepens Eye Research Institute, Ocular Genomics Institute/Massachusetts Eye and Ear Infirmary, Boston, MA, USA
-Currently: Interdisciplinary Centre of Biotechnology at Lublin Catholic University John Paul II

Gallery

Development and commercialization of inProbe by SDS Optic supported by:

partner SDS Optic partner SDS Optic partner SDS Optic partner SDS Optic partner SDS Optic partner SDS Optic partner SDS Optic

Website design co-financed under the European Regional Developent Fund